DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TYSABRI (natalizumab)
       *****************************************************
       #Post#: 2699--------------------------------------------------
       Natalizumab and liver injury research information (PubMed)
       By: agate Date: October 25, 2019, 11:56 pm
       ---------------------------------------------------------
       The Overview section of segment on natalizumab in the report
       entitled "LiverTox: Clinical and research information on
       drug-induced liver injury" from the National Institute of
       Diabetes and Digestive and Kidney Diseases. There is apparently
       no "likelihood score" (defined as "likely cause of clinically
       apparent liver injury") included for natalizumab.
       [font=verdana]
  HTML https://www.ncbi.nlm.nih.gov/books/NBK548623/#Natalizumab.OVERVIEW[/font]
       *****************************************************